INDP icon

Indaptus Therapeutics

16 hedge funds and large institutions have $93.7M invested in Indaptus Therapeutics in 2017 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Holders
16
Holders Change
+10
Holders Change %
+166.67%
% of All Funds
0.4%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
11
Increased
3
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
ACP
1
Acuta Capital Partners
California
$24.4M 2,724,283 +2,324,283 +581%
ACA
2
Avoro Capital Advisors
New York
$19.7M 2,195,705 +2,195,705 New
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$15.4M 1,725,000 +1,725,000 New
EC
4
EcoR1 Capital
California
$13.4M 1,500,000 +1,500,000 New
CAM
5
Cormorant Asset Management
Massachusetts
$7.25M 809,804
MIFH
6
Migdal Insurance & Financial Holdings
Israel
$4.67M 522,067 -133 -0%
SAM
7
Sectoral Asset Management
Quebec, Canada
$3.18M 355,000 +355,000 New
NC
8
Nexthera Capital
New York
$2.47M 276,324 +276,324 New
PVI
9
Pura Vida Investments
New York
$895K 100,000 +100,000 New
Renaissance Technologies
10
Renaissance Technologies
New York
$720K 80,400 +53,400 +198%
CC
11
Caxton Corporation
New Jersey
$681K 76,139 +76,139 New
Deutsche Bank
12
Deutsche Bank
Germany
$647K 72,350 +46,900 +184%
UBS Group
13
UBS Group
Switzerland
$289K 32,312 +32,312 New
Bank of America
14
Bank of America
North Carolina
$6K 626 +626 New
Morgan Stanley
15
Morgan Stanley
New York
$4K 400 +400 New
IA
16
IFP Advisors
Florida
$1K 100 +100 New
SM
17
Sabby Management
Florida
-92,701 Closed